000 | 01403 a2200385 4500 | ||
---|---|---|---|
005 | 20250511225109.0 | ||
264 | 0 | _c19901228 | |
008 | 199012s 0 0 eng d | ||
022 | _a0021-9738 | ||
024 | 7 |
_a10.1172/JCI114853 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLantz, M | |
245 | 0 | 0 |
_aCharacterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cNov 1990 |
||
300 |
_a1396-1402 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aChromatography, Gel |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aFibrosarcoma |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 | _aPrecipitin Tests |
650 | 0 | 4 |
_aReceptors, Cell Surface _xbiosynthesis |
650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
700 | 1 | _aGullberg, U | |
700 | 1 | _aNilsson, E | |
700 | 1 | _aOlsson, I | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 86 _gno. 5 _gp. 1396-1402 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI114853 _zAvailable from publisher's website |
999 |
_c2179845 _d2179845 |